In our study, we found that BEZ235 downregulated the expression of cyclin D1 and cyclin D3 in NSCLC cells via both transcriptional repression and proteasome-mediated degradation, resulting in cell cycle arrest at G1 phase. Here, CCND1 is linked to non-small cell lung carcinoma.